FDA
Articles tagged with “FDA”
3 articles
Trump Signs EO to Speed Psychedelic Research & Access
President Trump signed an executive order accelerating psychedelic research and access in April 2026. Here's what it means for ketamine therapy patients.
Read
news
NRx's Preservative-Free Ketamine Moves Through FDA Review
NRx Pharmaceuticals reports progress on its FDA application for a preservative-free ketamine formulation. What patients should know about this development.
news
Psychedelics Executive Order: What It Means for Ketamine Patients
A new executive order targeting psychedelic medicines is reshaping the regulatory landscape. Here's what ketamine therapy patients should understand.